Tagista
Tagista is a medication used to treat symptoms associated with balance disorders, particularly vertigo. It contains Betahistine, which helps improve blood flow in the inner ear, reducing the pressure and alleviating vertigo symptoms. Tagista is particularly effective for those suffering from Meniere's disease, a condition characterized by episodes of dizziness, tinnitus, and hearing loss. The tablets are designed to be taken orally and are absorbed efficiently to provide relief. By enhancing vestibular compensation, Tagista aids in restoring normal balance and reducing dizziness. This medication is well-regarded for its ability to manage chronic vertigo and improve overall quality of life. Regular use as prescribed can help maintain symptom control.Active substance:
Betahistine dihydrochloridePharmachologic effect:
Betahistine is a histamine analog that improves microcirculation in the inner ear, reducing endolymphatic pressure and alleviating symptoms of vertigo, tinnitus, and hearing loss associated with Ménière's disease.Indications:
- Ménière's disease
- Vestibular vertigo
- Tinnitus
Contraindications:
- Pheochromocytoma
- Hypersensitivity to betahistine or any of the excipients
- Peptic ulcer disease
Side effects:
In order of decreasing probability: Nausea, Dyspepsia, Headache, Allergic skin reactions (e.g., rash, pruritus)
Dosing and Administration:
The recommended starting dose is 8-16 mg taken three times a day with meals. The maintenance dose is usually 24-48 mg per day. The dosage may be adjusted based on clinical response.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Tagista
in Cyrillic : Тагиста
SUBSTANCE
Betahistine
DOSAGE FORM
tablets
